TriSalus Life Sciences (TLSI) Other financing activities (2023 - 2026)

TriSalus Life Sciences (TLSI) has 4 years of Other financing activities data on file, last reported at $263000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities fell 49.42% year-over-year to $263000.0; the trailing twelve-month figure through Mar 2026 stood at $243000.0 (down 92.21% YoY), and the FY2025 full-year result was $500000.0, down 80.77% from the prior year.
• Other financing activities for Q1 2026 stood at $263000.0, up from -$20000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $2.6 million in Q4 2024 and bottomed at -$2.6 million in Q3 2024.
• The 4-year median for Other financing activities is $231316.5 (2023), against an average of $336300.0.
• The widest annual swing landed in 2024, when Other financing activities jumped 1398.88%; it then sank 100.77% in 2025.
• A 4-year view of Other financing activities shows it stood at -$199633.0 in 2023, then surged by 1402.39% to $2.6 million in 2024, then tumbled by 100.77% to -$20000.0 in 2025, then surged by 1415.0% to $263000.0 in 2026.
• The last three Other financing activities figures came in at $263000.0 (Q1 2026), -$20000.0 (Q4 2025), and -$1.0 million (Q3 2025), per Business Quant data.

Peer Comparison